These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 28569236)

  • 41. Olopatadine nasal spray for the treatment of seasonal allergic rhinitis in patients aged 6 years and older.
    Roland PS; Ryan MW; Wall GM
    Expert Opin Pharmacother; 2010 Jun; 11(9):1559-67. PubMed ID: 20482305
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effectiveness of fluticasone furoate 110 microg once daily in the treatment of nasal and ocular symptoms of seasonal allergic rhinitis in adults and adolescents sensitized to mountain cedar pollen.
    Jacobs R; Martin B; Hampel F; Toler W; Ellsworth A; Philpot E
    Curr Med Res Opin; 2009 Jun; 25(6):1393-401. PubMed ID: 19419338
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Intranasal fluticasone propionate is more effective than terfenadine tablets for seasonal allergic rhinitis.
    van Bavel J; Findlay SR; Hampel FC; Martin BG; Ratner P; Field E
    Arch Intern Med; 1994 Dec 12-26; 154(23):2699-704. PubMed ID: 7993153
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of intranasal fluticasone furoate and intraocular olopatadine on nasal and ocular allergen-induced symptoms.
    Baroody FM; Logothetis H; Vishwanath S; Bashir M; Detineo M; Naclerio RM
    Am J Rhinol Allergy; 2013 Jan; 27(1):48-53. PubMed ID: 23406601
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Nasal budesonide offers superior symptom relief in perennial allergic rhinitis in comparison to nasal azelastine.
    Stern MA; Wade AG; Ridout SM; Cambell LM
    Ann Allergy Asthma Immunol; 1998 Oct; 81(4):354-8. PubMed ID: 9809500
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Fluticasone propionate aqueous nasal spray compared with oral loratadine in patients with seasonal allergic rhinitis.
    Géhanno P; Desfougeres JL
    Allergy; 1997 Apr; 52(4):445-50. PubMed ID: 9188929
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Safety of a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate in children: A randomized clinical trial.
    Berger W; Sher E; Gawchik S; Fineman S
    Allergy Asthma Proc; 2018 Mar; 39(2):110-116. PubMed ID: 29490769
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of olopatadine-mometasone combination nasal spray on seasonal allergic rhinitis symptoms in an environmental exposure chamber study.
    Patel P; Salapatek AM; Tantry SK
    Ann Allergy Asthma Immunol; 2019 Feb; 122(2):160-166.e1. PubMed ID: 30321655
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Efficacy of MP-AzeFlu in children with seasonal allergic rhinitis: Importance of paediatric symptom assessment.
    Berger W; Meltzer EO; Amar N; Fox AT; Just J; Muraro A; Nieto A; Valovirta E; Wickman M; Bousquet J
    Pediatr Allergy Immunol; 2016 Mar; 27(2):126-33. PubMed ID: 26928753
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The efficacy of intranasal fluticasone propionate in the relief of ocular symptoms associated with seasonal allergic rhinitis.
    DeWester J; Philpot EE; Westlund RE; Cook CK; Rickard KA
    Allergy Asthma Proc; 2003; 24(5):331-7. PubMed ID: 14619333
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison of the effects of fluticasone propionate, aqueous nasal spray and levocabastine on inflammatory cells in nasal lavage and clinical activity during the pollen season in seasonal rhinitics.
    Di Lorenzo G; Gervasi F; Drago A; Esposito Pellitteri M; Di Salvo A; Cosentino D; Potestio M; Colombo A; Candore G; Mansueto S; Caruso C
    Clin Exp Allergy; 1999 Oct; 29(10):1367-77. PubMed ID: 10520057
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A comparison of aqueous suspensions of budesonide nasal spray (128 micrograms and 256 micrograms once daily) and fluticasone propionate nasal spray (200 micrograms once daily) in the treatment of adult patients with seasonal allergic rhinitis.
    Stern MA; Dahl R; Nielsen LP; Pedersen B; Schrewelius C
    Am J Rhinol; 1997; 11(4):323-30. PubMed ID: 9292184
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Improved quality of life among seasonal allergic rhinitis patients treated with olopatadine HCl nasal spray 0.4% and olopatadine HCl nasal spray 0.6% compared with vehicle placebo.
    Hampel FC; Ratner PH; Amar NJ; van Bavel JH; Mohar D; Fairchild CJ; Wall GM; Brubaker MJ; Drake M; Crenshaw KM
    Allergy Asthma Proc; 2006; 27(3):202-7. PubMed ID: 16913262
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficacy and safety of azelastine nasal spray at a dose of 1 spray per nostril twice daily.
    Lumry W; Prenner B; Corren J; Wheeler W
    Ann Allergy Asthma Immunol; 2007 Sep; 99(3):267-72. PubMed ID: 17910331
    [TBL] [Abstract][Full Text] [Related]  

  • 55. An integrated analysis of the efficacy of fluticasone furoate nasal spray versus placebo on the nasal symptoms of perennial allergic rhinitis.
    Wu W; Walters RD; Nadeau GA; Botnick W; Broughton N
    Allergy Asthma Proc; 2013; 34(3):283-91. PubMed ID: 23676578
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of intranasal ciclesonide, oral levocetirizine, and combination treatment for allergic rhinitis.
    Kim CH; Kim JK; Kim HJ; Cho JH; Kim JS; Kim YD; Lee HM; Kim SW; Cho KS; Lee SH; Rhee CS; Dhong HJ; Rha KS; Yoon JH
    Allergy Asthma Immunol Res; 2015 Mar; 7(2):158-66. PubMed ID: 25729623
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of once-daily fluticasone furoate nasal spray on nasal symptoms in adults and adolescents with perennial allergic rhinitis.
    Nathan RA; Berger W; Yang W; Cheema A; Silvey M; Wu W; Philpot E
    Ann Allergy Asthma Immunol; 2008 May; 100(5):497-505. PubMed ID: 18517084
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mometasone furoate nasal spray plus oxymetazoline nasal spray: short-term efficacy and safety in seasonal allergic rhinitis.
    Meltzer EO; Bernstein DI; Prenner BM; Berger WE; Shekar T; Teper AA
    Am J Rhinol Allergy; 2013; 27(2):102-8. PubMed ID: 23562197
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Nasal immune gene expression in response to azelastine and fluticasone propionate combination or monotherapy.
    Watts AM; West NP; Smith PK; Zhang P; Cripps AW; Cox AJ
    Immun Inflamm Dis; 2022 Mar; 10(3):e571. PubMed ID: 34813682
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Safety and efficacy of desloratadine 5 mg in asthma patients with seasonal allergic rhinitis and nasal congestion.
    Berger WE; Schenkel EJ; Mansfield LE;
    Ann Allergy Asthma Immunol; 2002 Nov; 89(5):485-91. PubMed ID: 12452207
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.